Published in Eur J Heart Fail on December 01, 2011
Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev (2010) 6.49
Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J (2005) 3.50
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Common variants near TERC are associated with mean telomere length. Nat Genet (2010) 2.98
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J (2005) 2.92
Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol (2007) 2.36
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J (2013) 2.32
Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study. Eur J Epidemiol (2007) 2.18
The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol (2003) 2.12
Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE. Eur J Heart Fail (2005) 2.06
Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A (2011) 2.01
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol (2011) 1.89
Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail (2009) 1.88
The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J (2008) 1.85
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J (2007) 1.69
Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler Thromb Vasc Biol (2010) 1.68
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail (2012) 1.67
IVC diameter in patients with chronic heart failure: relationships and prognostic significance. JACC Cardiovasc Imaging (2013) 1.59
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia. Cardiovasc Drugs Ther (2008) 1.57
Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail (2003) 1.54
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail (2012) 1.51
Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2010) 1.51
Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells (2009) 1.50
Prognostic significance of different measures of the ventilation-carbon dioxide relation in patients with suspected heart failure. Eur J Heart Fail (2011) 1.48
Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur Heart J (2005) 1.48
Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype? Heart Rhythm (2012) 1.46
The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction. Eur J Heart Fail (2010) 1.43
Suicidal erythrocyte death, eryptosis, as a novel mechanism in heart failure-associated anaemia. Cardiovasc Res (2013) 1.43
Telomere biology in healthy aging and disease. Pflugers Arch (2009) 1.41
Development of a composite model derived from cardiopulmonary exercise tests to predict mortality risk in patients with mild-to-moderate heart failure. Heart (2014) 1.41
Biomechanical efficiency is impaired in patients with chronic heart failure. Eur J Heart Fail (2007) 1.41
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. Eur J Heart Fail (2003) 1.41
A case of cough and breathlessness. Thorax (2012) 1.40
Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail (2011) 1.40
[Almanac 2011: heart failure. An editorial overview of selected research that has driven recent advances in clinical cardiology]. G Ital Cardiol (Rome) (2011) 1.39
Is research declining amongst gastroenterology trainees in the United Kingdom? Clin Med (2013) 1.39
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail (2006) 1.38
Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc Biol (2012) 1.37
Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. Am J Physiol Renal Physiol (2006) 1.36
The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure. Eur Heart J (2005) 1.30
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30
The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J (2003) 1.28
Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet (2009) 1.25
Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J (2005) 1.24
Longitudinal ventricular function: normal values of atrioventricular annular and myocardial velocities measured with quantitative two-dimensional color Doppler tissue imaging. J Am Soc Echocardiogr (2003) 1.24
Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure. Eur J Heart Fail (2004) 1.24
The cardioprotective effects of metformin. Curr Opin Lipidol (2011) 1.19
Physiological interaction of heart and lung in thoracic irradiation. Int J Radiat Oncol Biol Phys (2012) 1.19
Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol (2002) 1.18
Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail (2013) 1.16
Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol (2007) 1.16
Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure. Cardiovasc Diabetol (2011) 1.14
Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail (2010) 1.14
Renal artery stenosis: an innocent bystander or an independent predictor of worse outcome in patients with chronic heart failure? A magnetic resonance imaging study. Eur J Heart Fail (2012) 1.14
Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J (2007) 1.13
Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest (2005) 1.13
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J (2009) 1.12
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J (2006) 1.11
The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. J Steroid Biochem Mol Biol (2012) 1.10
Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Am J Physiol Heart Circ Physiol (2011) 1.10
Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J (2010) 1.09
European Society of Cardiology Heart Failure Association Standards for delivering heart failure care. Eur J Heart Fail (2010) 1.09
Why does chronic heart failure cause breathlessness and fatigue? Prog Cardiovasc Dis (2007) 1.09
Left ventricular morphology, global and longitudinal function in normal older individuals: a cardiac magnetic resonance study. Int J Cardiol (2006) 1.08
Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol (2003) 1.07
Resting left ventricular function, however measured, is poorly related to exercise capacity in chronic heart failure. Am J Cardiol (2006) 1.07
The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure. Eur J Heart Fail (2005) 1.06
Does speckle tracking really improve diagnosis and risk stratification in patients with HF with normal EF? J Am Coll Cardiol (2014) 1.05
Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. Eur J Heart Fail (2010) 1.05
Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years' experience. Eur J Heart Fail (2013) 1.05
Telomere length and psychological well-being in patients with chronic heart failure. Age Ageing (2010) 1.04
Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol (2002) 1.02
Aging, telomeres and heart failure. Heart Fail Rev (2010) 1.02
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol (2012) 1.01
New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: comparison with cardiac magnetic resonance. Eur J Echocardiogr (2006) 1.01
Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial). Am Heart J (2013) 1.01
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res (2010) 1.00
The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med (2015) 1.00
Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy. Circ Cardiovasc Genet (2011) 0.99
Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail (2012) 0.99
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. Cardiovasc Res (2008) 0.99
Lack of diastolic reserve in patients with heart failure and normal ejection fraction. Circ Heart Fail (2009) 0.98
New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev (2012) 0.98
Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring. PLoS One (2011) 0.97
Bone marrow dysfunction in chronic heart failure patients. Eur J Heart Fail (2010) 0.97
Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease. Eur J Endocrinol (2008) 0.97
Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am J Cardiol (2008) 0.97
Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev (2012) 0.96
Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol (2006) 0.96